AI as a Healthcare Equalizer: How SARC MedIQ is Bringing Advanced Medical Imaging to Underserved Communities
Dario Priolo
Life Sciences Investor and Advisor | 5x B2B CMO - 13x M&A | Biopharma & Medtech Specialist | Publisher of "The AI in Healthcare Monitor" Newsletter
In rural clinics and community hospitals across America, a technological revolution is quietly unfolding. Healthcare providers who once lacked access to advanced diagnostic tools are now leveraging artificial intelligence to deliver care that rivals what's available at prestigious urban medical centers. At the heart of this transformation is SARC MedIQ, a company with an unusual mission in the healthcare AI space: to serve the underserved first.
While most healthcare technology companies target large hospital systems and academic medical centers, SARC MedIQ has deliberately focused on small to mid-sized healthcare facilities in underserved communities. Their AI-powered medical imaging platform is now deployed in over 300 healthcare facilities, serving more than 1,500 physicians and having analyzed over 10 million patient data points.
Targeting the Underserved by Design
"The most sick people are in the most underserved community, not because they have the worst health metrics. It's under-diagnosed," says Asaad Hakeem, CEO and founder of SARC MedIQ, in a recent interview. This insight forms the foundation of the company's strategic approach.
Rather than following the traditional path of targeting large hospital systems first, SARC MedIQ has deliberately chosen to focus on facilities that typically don't receive attention from major healthcare tech companies.
"Our major market segment is small to mid-size market, the underserved community. Why? Because no one is going there, and they are the ones who are struggling the most," explains Hakeem. "Usually you go top down, you get your few lighthouses so that the revenue is coming in. But I believe that if we don't serve the underserved, we will never serve the underserved."
Transforming Diagnostic Capabilities
SARC MedIQ's platform functions as an AI assistant for doctors and technologists, specializing in diagnostic automation for medical imaging. The system currently focuses primarily on ultrasound and X-ray analysis, with particular strength in cardiovascular imaging.
One of the most significant impacts of the technology is its ability to drastically reduce diagnostic time. As Hakeem describes it: "Think of a sonographer spending 45 minutes to an hour in your exam room with the patient and focusing on doing so many things like what's wrong with the patient, and doing a lot of measurements and clicks. What AI does is it reduces that time to under 10 minutes."
This efficiency gain translates directly into improved patient care. Clinicians can see more patients, detect conditions earlier, and provide more timely interventions. For cardiovascular conditions—the number one chronic reason for patient death, according to Hakeem—earlier detection through AI-enhanced imaging can make a critical difference in outcomes.
Leveling the Playing Field
Perhaps most importantly, SARC MedIQ's technology helps standardize care quality across different healthcare settings, regardless of resources or expertise.
"It levels the play field for you," notes Hakeem. "You're doing this in a high volume location where you have great readers, versus you are in Africa and you have not so great readers. The AI has a high mind, so it's going to detect whether you are in Africa or in Europe."
This standardization addresses a fundamental inequity in healthcare: the quality of care often depends heavily on where patients live and which facilities they can access. By making expert-level diagnostic capabilities available regardless of location, SARC MedIQ is working to ensure that patients in rural and underserved areas receive the same quality of care as those in major metropolitan medical centers.
A Platform for Preventive Care
Beyond improving diagnostic capabilities, SARC MedIQ's technology facilitates a shift toward preventive care—detecting conditions early before they become chronic or life-threatening.
"What we are doing is we are doing early detection and preventive diagnosis, so treatment is done early, so that doesn't become chronic, keeps them out of the hospital," Hakeem explains.
This approach not only improves individual patient outcomes but also reduces the overall burden on the healthcare system, "putting a lesser comfort burden on the federal health system that is mandated to provide healthcare for the underserved."
Building Trust Through Performance
Implementing new AI technology in healthcare settings often faces initial resistance. SARC MedIQ has approached this challenge by framing their AI as an additional team member rather than a replacement for human expertise.
"They're mostly excited about it. They are initially skeptical, but once they develop trust... we call it 'Hey, you are hiring another clinician, or you're hiring another assistant for yourself,'" says Hakeem. "So you first evaluate that assistant for a few weeks, for a few months, once you get comfortable with it, then that becomes part of your workflow."
This approach has helped the company overcome initial skepticism as clinicians experience the system's benefits firsthand.
Making Advanced Technology Affordable
Accessibility isn't just about geographic availability—it's also about affordability. SARC MedIQ has adopted what Hakeem describes as a "Netflix model" for their business: a subscription-based, pay-as-you-go approach that makes the technology financially accessible to smaller facilities with limited budgets.
"Everyone in the intercept community is the primary focus is, does it work and is it affordable?" says Hakeem. "And we check those boxes."
This pricing strategy represents a departure from the high upfront costs typical of many healthcare technology implementations. By removing financial barriers to adoption, SARC MedIQ further democratizes access to advanced diagnostic capabilities.
The Path Forward
As SARC MedIQ continues to grow, the company is expanding its capabilities beyond cardiovascular imaging into other areas including women's health, pediatrics, and orthopedics. They're also developing partnerships with major medical equipment manufacturers like GE, Philips, and Siemens to further extend their reach.
"The strategy was working with the manufacturers and vendors, so GE, Philips, Siemens and their staff," Hakeem explains. "Everyone needs hardware, but the software that goes with that hardware is very expensive, even for these vendors. That's why the underserved community had a gap."
By providing software that works effectively with existing hardware, SARC MedIQ enables these manufacturers to sell their equipment "much more complacently and much more confidently" to facilities that might otherwise struggle to afford or effectively utilize advanced imaging technology.
In an era where technological advances often widen existing disparities, SARC MedIQ offers a compelling counterexample—proof that with the right mission and approach, AI can help close healthcare gaps rather than expand them.
"If you are customer obsessed and serving the underserved community," Hakeem reflects, "that that really rose the product market fit."
? 2025 AI in Healthcare Monitor. All rights reserved.
Standardizing diagnostic quality across locations is one of AI’s greatest strengths. Whether in a major hospital or a rural clinic, patients should receive the same level of care. SARC MedIQ’s approach proves that technology can make that a reality.
The 10-minute AI-assisted ultrasound workflow is a breakthrough. Reducing exam time from nearly an hour to under 10 minutes means more patients seen, more conditions detected, and ultimately, better patient care—without sacrificing accuracy.
The idea that “the sickest people aren’t always the least healthy, just under-diagnosed” is a powerful reminder of how inequities in healthcare access shape outcomes. SARC MedIQ’s work tackles this issue head-on, ensuring patients get the right diagnosis at the right time.
The company’s strategy of integrating with existing hardware from GE, Philips, and Siemens is a game-changer. Rather than requiring costly new infrastructure, they’re enhancing what’s already in place—making adoption far more feasible for resource-limited facilities.
Cardiovascular disease remains the leading cause of death worldwide, yet diagnostic access varies drastically by region. AI-driven imaging solutions like this can help close the gap, ensuring that life-saving early detection isn’t limited to urban hospitals.